Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2023-09-05 Director's Dealing
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 206.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details the change in securities holdings of a company director, including the number of shares held before and after the change, the nature of the interest, and the transaction details. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's personal share transactions, which fits the definition of 'Director's Dealing' filings. The document length is 2995 characters, which is typical for such notices. Therefore, the correct classification is DIRS (Director's Dealing).
2023-09-05 English
Application for quotation of securities - HLS 7 pages 30.5KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities issued under an employee incentive scheme by Healius Limited. It details the number and type of securities to be quoted, issue dates, and information about key management personnel receiving securities. The document is a formal announcement related to the listing of new securities on the ASX and does not contain financial statements, management discussion, or detailed financial results. It is not a report but an announcement about capital changes related to securities issuance and quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief notice but a detailed application for quotation, consistent with SHA filings.
2023-09-04 English
Application for quotation of securities - HLS 7 pages 30.5KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities issued under an employee incentive scheme by Healius Limited. It details the number and type of securities to be quoted, issue dates, and compliance with ASX listing rules. There is no financial performance data, earnings information, or management discussion. The document is an announcement related to capital market activity, specifically the quotation of new securities. This fits the definition of a Share Issue/Capital Change announcement rather than a full financial report or other categories.
2023-09-03 English
Initial Director's Interest Notice 2 pages 191.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the appointment date of a director and discloses the director's relevant interests in securities and contracts, with no securities held. This matches the description of a Director's Dealing report, which involves reporting personal share transactions or interests by company directors. The document length is short and focused solely on director interests, not financial results or other report types. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-08-31 English
Preliminary Final Report 31 pages 351.7KB
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E – Preliminary Final Report (Unaudited)' for the year ended 30 June 2023, which is a regulatory filing format used in Australia for preliminary final reports. It contains detailed financial statements including consolidated profit or loss, comprehensive income, financial position, cash flows, and notes. It also includes a comprehensive review of operations, divisional results, cash flow and gearing analysis, and reconciliations between underlying and reported profits. The document is 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed financial data and analysis confirms it is a comprehensive financial report for a full fiscal year. This matches the definition of an Annual Report (10-K equivalent) rather than a simple announcement or a quarterly/interim report. Therefore, the correct classification is Annual Report (10-K). FY 2023
2023-08-29 English
HLS Media Release FY 2023 Results 3 pages 169.0KB
Annual Report Classification · 95% confidence The document is an ASX announcement dated 30 August 2023 reporting Healius Limited's financial results for the fiscal year ended 30 June 2023. It includes detailed financial figures such as revenue, EBIT, impairment charges, and gearing ratios, as well as commentary on divisional performance, balance sheet, dividend decisions, and outlook. The content is comprehensive and covers the full fiscal year, indicating it is a full annual financial report rather than a brief earnings release or a simple announcement. The length of the document (7,338 characters) and the presence of detailed financial data and management commentary support classification as an Annual Report. There is no indication that this is merely an announcement of a report or a certification letter, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2023
2023-08-29 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.